JP2023538369A5 - - Google Patents
Info
- Publication number
- JP2023538369A5 JP2023538369A5 JP2023511960A JP2023511960A JP2023538369A5 JP 2023538369 A5 JP2023538369 A5 JP 2023538369A5 JP 2023511960 A JP2023511960 A JP 2023511960A JP 2023511960 A JP2023511960 A JP 2023511960A JP 2023538369 A5 JP2023538369 A5 JP 2023538369A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- antigen
- sequence
- binding fragment
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010828886.4 | 2020-08-17 | ||
| CN202010828886 | 2020-08-17 | ||
| CN202011152518 | 2020-10-23 | ||
| CN202011152518.9 | 2020-10-23 | ||
| PCT/CN2021/112771 WO2022037531A1 (zh) | 2020-08-17 | 2021-08-16 | 抗cd73的抗体及其用途 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023538369A JP2023538369A (ja) | 2023-09-07 |
| JP2023538369A5 true JP2023538369A5 (https=) | 2024-08-26 |
Family
ID=80283259
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023511960A Pending JP2023538369A (ja) | 2020-08-17 | 2021-08-16 | 抗ｃｄ７３抗体とその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240218074A1 (https=) |
| EP (1) | EP4197555A4 (https=) |
| JP (1) | JP2023538369A (https=) |
| CN (1) | CN114075289B (https=) |
| AU (1) | AU2021326889A1 (https=) |
| CA (1) | CA3191745A1 (https=) |
| WO (1) | WO2022037531A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240218073A1 (en) * | 2019-11-01 | 2024-07-04 | Corvus Pharmaceuticals, Inc. | Immunomodulatory anti-cd73 antibodies and uses thereof |
| US20240368299A1 (en) * | 2022-04-28 | 2024-11-07 | Xintrum Pharmaceuticals, Ltd. | Anti-human CD73 monoclonal antibody without hook effect |
| CN117304316A (zh) * | 2022-06-22 | 2023-12-29 | 复旦大学 | 靶向cd73的纳米抗体及纳米抗体-药物偶联物、其制备方法和用途 |
| WO2024040194A1 (en) | 2022-08-17 | 2024-02-22 | Capstan Therapeutics, Inc. | Conditioning for in vivo immune cell engineering |
| AU2024279278A1 (en) | 2023-05-31 | 2025-12-18 | Capstan Therapeutics, Inc. | Lipid nanoparticle formulations and compositions |
| US20250127728A1 (en) | 2023-10-05 | 2025-04-24 | Capstan Therapeutics, Inc. | Constrained Ionizable Cationic Lipids and Lipid Nanoparticles |
| WO2025076113A1 (en) | 2023-10-05 | 2025-04-10 | Capstan Therapeutics, Inc. | Ionizable cationic lipids with conserved spacing and lipid nanoparticles |
| US20250302763A1 (en) | 2024-02-22 | 2025-10-02 | Capstan Therapeutics, Inc. | Immune engineering amplification |
| WO2025217452A1 (en) | 2024-04-11 | 2025-10-16 | Capstan Therapeutics, Inc. | Constrained ionizable cationic lipids and lipid nanoparticles |
| WO2025217454A2 (en) | 2024-04-11 | 2025-10-16 | Capstan Therapeutics, Inc. | Ionizable cationic lipids and lipid nanoparticles |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| EP3204417B1 (en) * | 2014-10-10 | 2020-07-22 | Innate Pharma | Cd73 blockade |
| WO2016131950A1 (en) * | 2015-02-20 | 2016-08-25 | Innate Pharma | Cd73 blockade |
| GB2537445A (en) * | 2014-11-10 | 2016-10-19 | Medimmune Ltd | Binding molecules specific for CD73 and uses thereof |
| GB2538120A (en) * | 2014-11-11 | 2016-11-09 | Medimmune Ltd | Therapeutic combinations comprising anti-CD73 antibodies and uses thereof |
| AU2015349878A1 (en) * | 2014-11-21 | 2017-05-25 | Bristol-Myers Squibb Company | Antibodies against CD73 and uses thereof |
| CN104558137A (zh) * | 2015-01-15 | 2015-04-29 | 浙江欧诗漫生物股份有限公司 | 一种珍珠蛋白的制备方法及该方法制备得到的水溶性珍珠蛋白和酸溶性珍珠蛋白 |
| US11130817B2 (en) * | 2015-10-12 | 2021-09-28 | Innate Pharma | CD73 blocking agents |
| CN114805575B (zh) * | 2015-12-09 | 2024-07-23 | 科尔沃斯制药股份有限公司 | 人源化抗cd73抗体 |
| EP3423494A1 (en) * | 2016-03-04 | 2019-01-09 | Bristol-Myers Squibb Company | Combination therapy with anti-cd73 antibodies |
| RU2754058C2 (ru) * | 2016-12-13 | 2021-08-26 | Астеллас Фарма Инк. | Антитело к cd73 человека |
| CA3045376C (en) * | 2017-01-24 | 2022-08-30 | I-Mab | Anti-cd73 antibodies and uses thereof |
| US11530273B2 (en) * | 2017-05-23 | 2022-12-20 | Helmholtz Zentrum München—Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) | Anti-CD73 monoclonal antibody, encoding nucleic acids and method for producing |
| MY204117A (en) * | 2017-06-22 | 2024-08-08 | Novartis Ag | Antibody molecules to cd73 and uses thereof |
| CN110240654A (zh) * | 2018-03-07 | 2019-09-17 | 复旦大学 | 结合cd73的抗体-药物偶联物 |
| EP3762030A4 (en) * | 2018-03-09 | 2022-01-05 | Phanes Therapeutics, Inc. | ANTI-CD73 ANTIBODIES AND USES THEREOF |
| WO2019173692A2 (en) * | 2018-03-09 | 2019-09-12 | Agenus Inc. | Anti-cd73 antibodies and methods of use thereof |
-
2021
- 2021-08-16 US US18/021,167 patent/US20240218074A1/en active Pending
- 2021-08-16 JP JP2023511960A patent/JP2023538369A/ja active Pending
- 2021-08-16 CA CA3191745A patent/CA3191745A1/en active Pending
- 2021-08-16 EP EP21857625.4A patent/EP4197555A4/en active Pending
- 2021-08-16 AU AU2021326889A patent/AU2021326889A1/en active Pending
- 2021-08-16 CN CN202110939980.1A patent/CN114075289B/zh active Active
- 2021-08-16 WO PCT/CN2021/112771 patent/WO2022037531A1/zh not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023538369A5 (https=) | ||
| US10125188B2 (en) | Human antibodies to respiratory syncytial virus F protein and methods of use thereof | |
| KR101671452B1 (ko) | 항ｒｓｖ ｇ 단백질 항체 | |
| US9861696B2 (en) | Monoclonal antibodies for Ebola and Marburg viruses | |
| CN115666649B (zh) | 一种新型冠状病毒抗体的药物组合物及其用途 | |
| JP2017518958A (ja) | 免疫原性グリコペプチドに対する抗体、それを含む組成物、及びそれらの使用 | |
| JP2023549067A5 (https=) | ||
| JP2020529835A5 (https=) | ||
| JP2015518369A (ja) | Ｂ型インフルエンザウイルスに結合して中和することができるヒト結合分子およびその使用 | |
| JP2011501656A5 (https=) | ||
| EP3360896B1 (en) | Antibody to hepatitis b surface antigen and use thereof | |
| RU2765878C2 (ru) | Антитела для лечения инфекции гепатитом в и связанных с ней заболеваний | |
| JP2024531151A5 (https=) | ||
| US20180237502A1 (en) | Pan-ebola and pan-filovirus protective epitopes, antibodies, and antibody cocktails | |
| WO2016078761A1 (en) | Antibodies that potently neutralize rabies virus and other lyssaviruses and uses thereof | |
| JP2024527607A5 (https=) | ||
| JP2010504759A (ja) | ライノウイルスの新規中和性免疫原（ｎｉｍｉｖ）およびワクチン応用のためのその利用 | |
| CN102216330B (zh) | 用于病毒所致的疾病的抗体药物组合物 | |
| JP2023511956A5 (https=) | ||
| CN114773461B (zh) | 乙型脑炎病毒抗体1d11及其应用 | |
| US20220340658A1 (en) | NEUTRALIZING ANTI-SARS-CoV-2 ANTIBODIES AND USE THEREOF | |
| CN112996540A (zh) | 一种c-Met ADC在制备治疗c-Met激酶抑制剂耐药的疾病的药物中的用途 | |
| CN113549146B (zh) | 针对柯萨奇病毒b1型的单克隆抗体及其用途 | |
| JP2022553703A5 (https=) | ||
| WO2022023292A9 (en) | Corona virus spike protein-targeting antibodies and use thereof |